LN-145
25-394
Phase 2 mab active
Quick answer
LN-145 for Cutaneous Squamous Cell Carcinoma is a Phase 2 program (mab) at Iovance Biotherapeutics B.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Iovance Biotherapeutics B.V.
- Indication
- Cutaneous Squamous Cell Carcinoma
- Phase
- Phase 2
- Modality
- mab
- Status
- active